Swedencare AB (publ) (LON:0ABG)

Revenue by Product

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Nutraceuticals	1.24B
Nutraceuticals Growth	35.25%
Topicals/Dermatology	555.60M
Topicals/Dermatology Growth	-1.34%
ProDen PlaqueOff	269.60M
ProDen PlaqueOff Growth	50.51%
Pharma	96.80M
Pharma Growth	5.29%
Other	162.90M
Other Growth	107.21%

Revenue by Geography

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
North America	1.83B
North America Growth	23.50%
Europe	432.20M
Europe Growth	149.51%
Rest of the World	65.40M
Rest of the World Growth	798.72%